Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway

Abstract Background Nuciferine (NF), extracted from the leaves of N. nucifera Gaertn, has been shown to exhibit anti-tumor and anti-viral pharmacological properties. It can also penetrate the blood brain barrier (BBB). However, the mechanism by which NF inhibits glioblastoma (GBM) progression is not...

Full description

Bibliographic Details
Main Authors: Zizhuo Li, Yaodong Chen, Tingting An, Pengfei Liu, Jiyuan Zhu, Haichao Yang, Wei Zhang, Tianxiu Dong, Jian Jiang, Yu Zhang, Maitao Jiang, Xiuhua Yang
Format: Article
Language:English
Published: BMC 2019-03-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13046-019-1134-y
_version_ 1819049308345860096
author Zizhuo Li
Yaodong Chen
Tingting An
Pengfei Liu
Jiyuan Zhu
Haichao Yang
Wei Zhang
Tianxiu Dong
Jian Jiang
Yu Zhang
Maitao Jiang
Xiuhua Yang
author_facet Zizhuo Li
Yaodong Chen
Tingting An
Pengfei Liu
Jiyuan Zhu
Haichao Yang
Wei Zhang
Tianxiu Dong
Jian Jiang
Yu Zhang
Maitao Jiang
Xiuhua Yang
author_sort Zizhuo Li
collection DOAJ
description Abstract Background Nuciferine (NF), extracted from the leaves of N. nucifera Gaertn, has been shown to exhibit anti-tumor and anti-viral pharmacological properties. It can also penetrate the blood brain barrier (BBB). However, the mechanism by which NF inhibits glioblastoma (GBM) progression is not well understood. We aimed to determine the anti-tumor effect of NF on GBM cell lines and clarify the potential molecular mechanism involved. Methods U87MG and U251 cell lines were used in vitro to assess the anti-tumor efficacy of NF. Cytotoxicity, viability, and proliferation were evaluated by MTT and colony formation assay. After Annexin V-FITC and PI staining, flow cytometry was performed to evaluate apoptosis and cell cycle changes in NF-treated GBM cells. Wound healing and Transwell assays were used to assess migration and invasion of GBM cells. Western blot analysis, immunofluorescence staining, immunohistochemistry, and bioinformatics were used to gain insights into the molecular mechanisms. Preclinical therapeutic efficacy was mainly estimated by ultrasound and MRI in xenograft nude mouse models. Results NF inhibited the proliferation, mobility, stemness, angiogenesis, and epithelial-to-mesenchymal transition (EMT) of GBM cells. Additionally, NF induced apoptosis and G2 cell cycle arrest. Slug expression was also decreased by NF via the AKT and STAT3 signaling pathways. Interestingly, we discovered that NF affected GBM cells partly by targeting SOX2, which may be upstream of the AKT and STAT3 pathways. Finally, NF led to significant tumor control in GBM xenograft models. Conclusions NF inhibited the progression of GBM via the SOX2-AKT/STAT3-Slug signaling pathway. SOX2-targeting with NF may offer a novel therapeutic approach for GBM treatment.
first_indexed 2024-12-21T11:30:05Z
format Article
id doaj.art-e6cfa8ab0de24a0cb10286e60e293941
institution Directory Open Access Journal
issn 1756-9966
language English
last_indexed 2024-12-21T11:30:05Z
publishDate 2019-03-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj.art-e6cfa8ab0de24a0cb10286e60e2939412022-12-21T19:05:35ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662019-03-0138111510.1186/s13046-019-1134-yNuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathwayZizhuo Li0Yaodong Chen1Tingting An2Pengfei Liu3Jiyuan Zhu4Haichao Yang5Wei Zhang6Tianxiu Dong7Jian Jiang8Yu Zhang9Maitao Jiang10Xiuhua Yang11Department of Abdominal Ultrasound, The First Affiliated Hospital of Harbin Medical UniversityDepartment of Abdominal Ultrasound, The First Affiliated Hospital of Harbin Medical UniversityDepartment of Abdominal Ultrasound, The First Affiliated Hospital of Harbin Medical UniversityDepartment of Magnetic Resonance, The First Affiliated Hospital of Harbin Medical UniversityDepartment of Pathology, The First Affiliated Hospital of Harbin Medical UniversityDepartment of Abdominal Ultrasound, The First Affiliated Hospital of Harbin Medical UniversityDepartment of Abdominal Ultrasound, The First Affiliated Hospital of Harbin Medical UniversityDepartment of Abdominal Ultrasound, The First Affiliated Hospital of Harbin Medical UniversityDepartment of Abdominal Ultrasound, The First Affiliated Hospital of Harbin Medical UniversityDepartment of Abdominal Ultrasound, The First Affiliated Hospital of Harbin Medical UniversityDepartment of Abdominal Ultrasound, The First Affiliated Hospital of Harbin Medical UniversityDepartment of Abdominal Ultrasound, The First Affiliated Hospital of Harbin Medical UniversityAbstract Background Nuciferine (NF), extracted from the leaves of N. nucifera Gaertn, has been shown to exhibit anti-tumor and anti-viral pharmacological properties. It can also penetrate the blood brain barrier (BBB). However, the mechanism by which NF inhibits glioblastoma (GBM) progression is not well understood. We aimed to determine the anti-tumor effect of NF on GBM cell lines and clarify the potential molecular mechanism involved. Methods U87MG and U251 cell lines were used in vitro to assess the anti-tumor efficacy of NF. Cytotoxicity, viability, and proliferation were evaluated by MTT and colony formation assay. After Annexin V-FITC and PI staining, flow cytometry was performed to evaluate apoptosis and cell cycle changes in NF-treated GBM cells. Wound healing and Transwell assays were used to assess migration and invasion of GBM cells. Western blot analysis, immunofluorescence staining, immunohistochemistry, and bioinformatics were used to gain insights into the molecular mechanisms. Preclinical therapeutic efficacy was mainly estimated by ultrasound and MRI in xenograft nude mouse models. Results NF inhibited the proliferation, mobility, stemness, angiogenesis, and epithelial-to-mesenchymal transition (EMT) of GBM cells. Additionally, NF induced apoptosis and G2 cell cycle arrest. Slug expression was also decreased by NF via the AKT and STAT3 signaling pathways. Interestingly, we discovered that NF affected GBM cells partly by targeting SOX2, which may be upstream of the AKT and STAT3 pathways. Finally, NF led to significant tumor control in GBM xenograft models. Conclusions NF inhibited the progression of GBM via the SOX2-AKT/STAT3-Slug signaling pathway. SOX2-targeting with NF may offer a novel therapeutic approach for GBM treatment.http://link.springer.com/article/10.1186/s13046-019-1134-yNuciferineGlioblastomaSOX2-AKT/STAT3-Slug signaling pathwayEMT
spellingShingle Zizhuo Li
Yaodong Chen
Tingting An
Pengfei Liu
Jiyuan Zhu
Haichao Yang
Wei Zhang
Tianxiu Dong
Jian Jiang
Yu Zhang
Maitao Jiang
Xiuhua Yang
Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway
Journal of Experimental & Clinical Cancer Research
Nuciferine
Glioblastoma
SOX2-AKT/STAT3-Slug signaling pathway
EMT
title Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway
title_full Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway
title_fullStr Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway
title_full_unstemmed Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway
title_short Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway
title_sort nuciferine inhibits the progression of glioblastoma by suppressing the sox2 akt stat3 slug signaling pathway
topic Nuciferine
Glioblastoma
SOX2-AKT/STAT3-Slug signaling pathway
EMT
url http://link.springer.com/article/10.1186/s13046-019-1134-y
work_keys_str_mv AT zizhuoli nuciferineinhibitstheprogressionofglioblastomabysuppressingthesox2aktstat3slugsignalingpathway
AT yaodongchen nuciferineinhibitstheprogressionofglioblastomabysuppressingthesox2aktstat3slugsignalingpathway
AT tingtingan nuciferineinhibitstheprogressionofglioblastomabysuppressingthesox2aktstat3slugsignalingpathway
AT pengfeiliu nuciferineinhibitstheprogressionofglioblastomabysuppressingthesox2aktstat3slugsignalingpathway
AT jiyuanzhu nuciferineinhibitstheprogressionofglioblastomabysuppressingthesox2aktstat3slugsignalingpathway
AT haichaoyang nuciferineinhibitstheprogressionofglioblastomabysuppressingthesox2aktstat3slugsignalingpathway
AT weizhang nuciferineinhibitstheprogressionofglioblastomabysuppressingthesox2aktstat3slugsignalingpathway
AT tianxiudong nuciferineinhibitstheprogressionofglioblastomabysuppressingthesox2aktstat3slugsignalingpathway
AT jianjiang nuciferineinhibitstheprogressionofglioblastomabysuppressingthesox2aktstat3slugsignalingpathway
AT yuzhang nuciferineinhibitstheprogressionofglioblastomabysuppressingthesox2aktstat3slugsignalingpathway
AT maitaojiang nuciferineinhibitstheprogressionofglioblastomabysuppressingthesox2aktstat3slugsignalingpathway
AT xiuhuayang nuciferineinhibitstheprogressionofglioblastomabysuppressingthesox2aktstat3slugsignalingpathway